NetworkNewsBreaks – Interpace Diagnostics (IDXG) Shares Soar on Word Aetna (AET) will Cover ThyraMir™ Test
Shares of Interpace Diagnostics Corp. (NASDAQ: IDXG) are up 205% following news that Aetna (NYSE: AET) has agreed to provide coverage of Interpace's ThyraMir™ test, effective immediately. Including Aetna’s 46 million members, ThyGenX™ and ThyraMir thyroid assays are now covered for approximately 200 million patients nationwide. The combination of both tests have been shown to reduce the rate of unnecessary thyroid surgeries in indeterminate cases (not clearly benign or malignant) by offering high predictive value in determining the presence and absence of cancer in thyroid nodules. "The acceptance by Aetna to cover both ThyGenX and ThyraMir is further support of the…







